Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 50.65M P/E - EPS this Y -12.80% Ern Qtrly Grth -
Income -25.79M Forward P/E -1.54 EPS next Y -22.70% 50D Avg Chg -22.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -13.00%
Dividend N/A Price/Book 1.42 EPS next 5Y - 52W High Chg -72.00%
Recommedations 1.70 Quick Ratio 3.07 Shares Outstanding 39M 52W Low Chg 62.00%
Insider Own 6.50% ROA -74.08% Shares Float 32.88M Beta 1.62
Inst Own 34.22% ROE -79.69% Shares Shorted/Prior 150.21K/126.75K Price 1.73
Gross Margin - Profit Margin - Avg. Volume 167,724 Target Price 6.67
Oper. Margin - Earnings Date May 4 Volume 29,537 Change 2.98%
About Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. The company was incorporated in 2007 and is headquartered in Purchase, New York.

Cognition Therapeutics, Inc. News
04/22/24 Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease
04/02/24 Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference
04/01/24 Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on April 12, 2024
03/27/24 Cognition Therapeutics, Inc. (NASDAQ:CGTX) Q4 2023 Earnings Call Transcript
03/27/24 Q4 2023 Cognition Therapeutics Inc Earnings Call
03/26/24 Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update
03/15/24 Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results
03/14/24 Cognition Therapeutics Announces Closing of $11.5 Million Public Offering of Common Stock
03/11/24 Cognition Therapeutics Announces Pricing of $11.5 Million Public Offering of Common Stock
03/11/24 Cognition Therapeutics Announces Proposed Public Offering of Common Stock
03/06/24 Cognition Therapeutics Presents Analyses at AD/PD™ 2024 Correlating Proteomic Findings with Treatment Effect of CT1812 in Alzheimer’s Disease Studies
02/26/24 Cognition Therapeutics to Present at the TD Cowen Health Care Conference
02/06/24 New Publication Identifies Key Proteins Involved in Amyloid Oligomer Binding and Supports Mechanism of CT1812
01/16/24 Here's Why We're Watching Cognition Therapeutics' (NASDAQ:CGTX) Cash Burn Situation
01/04/24 Cognition Therapeutics CEO Issues Letter to Shareholders
11/16/23 Cognition Therapeutics Releases New Episode of “Conversations” Podcast Recorded at CTAD with Quantitative EEG Experts, Drs Willem de Haan and Philip Scheltens
11/15/23 Cognition Therapeutics Presents Preclinical Data Identifying Pathways Impacted by Sigma-2 Receptor Modulators in Alzheimer’s and Parkinson’s Diseases
11/07/23 Cognition Therapeutics Completes Enrollment in Phase 2 SHINE Study of CT1812 in Mild-to-Moderate Alzheimer’s Disease
11/03/23 Cognition Therapeutics Inc (CGTX) Reports Q3 2023 Financial Results
11/02/23 Cognition Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
CGTX Chatroom

User Image ForestFoxes Posted - 8 hours ago

First PR between $AVXL and $CGTX https://www.cognision.com/neuronetrix-has-been-selected-by-anavex-life-sciences-corp-to-support-the-upcoming-phase-2a-clinical-trial-for-anavex-2-73/

User Image Stock_Titan Posted - 2 days ago

$CGTX Cognition Therapeutics KOL Event Provided Platform for Valuable Discussion of Current Therapeutic Options and Need for Additional Options to Treat Alzheimer’s Disease https://www.stocktitan.net/news/CGTX/cognition-therapeutics-kol-event-provided-platform-for-valuable-474mav38a60q.html

User Image DLBEE Posted - 5 days ago

$CGTX if this thing works sky is a limit. https://youtu.be/3UmC3fenCcY?si=7JuFDW2k5DRAlWSk

User Image mikesmic Posted - 5 days ago

$XBI 6 days of pure onslaught. $CGTX has held up well. It’s going to $6 EOY.

User Image DLBEE Posted - 5 days ago

$CGTX I should share this video from 8 months ago. https://youtu.be/ap-eyxo32Aw?si=Gp-ok1KZLPFUwVHW

User Image kornlover Posted - 1 week ago

$CGTX funny how every day the after hours price spikes. would love for one day to be actually realized!

User Image _bottomfishing_ Posted - 1 week ago

$MBOT $HALO $CGTX Analysts Are Bullish on Top Healthcare Stocks: https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-halozyme-halo-cognition-therapeutics-cgtx

User Image arthurkorff Posted - 1 week ago

$CGTX are weexpecting results soon? A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies Actual Study Start Date: June 22, 2022 Estimated Primary Completion Date: April 15, 2024

User Image celebratelife Posted - 1 week ago

$CGTX Lisa's nerves seem pumped. Video of the panel is finally out. Lisa Ricciardi is jittery and hyper as hell again. She almost knocks the glass off the table. Her frequency is very different than any other panel member -- everyone else is calm and gathered -- she's in a different nervous state, jittery, lots of movement, touching her nose, etc. It's very unsettling. I hope they get good data, and she sells the company and this is over with. I can't stand having such a nervous wreck of a CEO. There's a place for being excited but this is just too much, and may even deter some investors who want to put their money on someone (a CEO) who runs a business for them https://www.youtube.com/watch?v=AS3QcVjTPc8

User Image celebratelife Posted - 1 week ago

$CGTX GREAT presentation at Needham. If you missed it, the replay is still available: https://wsw.com/webcast/needham138/cgtx/2268084

User Image DLBEE Posted - 2 weeks ago

$CRVO who is going to get picked up first crvo or $CGTX

User Image celebratelife Posted - 2 weeks ago

$CGTX Nice 77,000 share buy at several cents above ask.

User Image Wontstopcantstop Posted - 2 weeks ago

$CGTX Just started a position. Hilarious how a 400 share order filled at $2 then dropped the bid back down to $1.76. 😂

User Image celebratelife Posted - 3 weeks ago

$CGTX Nice close! Up over 8%. Sign of things to come. 3 more days like this and we're at 2.50 and 3 more, at $3.14

User Image Stock_Titan Posted - 3 weeks ago

$CGTX Cognition Therapeutics to Present at the Needham Virtual Healthcare Conference https://www.stocktitan.net/news/CGTX/cognition-therapeutics-to-present-at-the-needham-virtual-healthcare-dn6593tgpl26.html

User Image StockMET Posted - 3 weeks ago

$CGTX keep an eye for the next 6 weeks, topline results will send this one 📳

User Image Stock_Titan Posted - 3 weeks ago

$CGTX Cognition Therapeutics to host Virtual KOL Event on the Evolving Landscape in Alzheimer’s Disease on April 12, 2024 https://www.stocktitan.net/news/CGTX/cognition-therapeutics-to-host-virtual-kol-event-on-the-evolving-qg3oymquimoq.html

User Image celebratelife Posted - 03/26/24

$CGTX GREAT CONFERENCE CALL Great quarterly call today. If you haven't listened, check it out. Multiple analysts are talking about the new universe for Cognition following June's data.

User Image DonCorleone77 Posted - 03/26/24

$CGTX Cognition Therapeutics reports FY23 EPS (86c) vs (91c) last year "We achieved a number of critical clinical objectives in 2023," said Lisa Ricciardi, Cognition's president and CEO. "We are pleased with the progress being made with our clinical trial partners to advance our Phase 2 studies. In addition, the scientific data generated by our team has continued to provide insights into proteins and biological processes impacted by CT1812 in Alzheimer's and Parkinson's diseases as well as dry AMD."

User Image Stock_Titan Posted - 03/26/24

$CGTX Cognition Therapeutics Reports Year End 2023 Financial Results and Provides Business Update https://www.stocktitan.net/news/CGTX/cognition-therapeutics-reports-year-end-2023-financial-results-and-umucrh7rqfes.html

User Image iizzy Posted - 03/25/24

$CGTX Finance report?

User Image celebratelife Posted - 1 month ago

$CGTX very favorable discount, reflecting the strong demand for the stock.

User Image Stocktwitssuspended Posted - 1 month ago

$CGTX this forum is dead

User Image celebratelife Posted - 1 month ago

$CGTX Based on information I received through channel checks: The secondary and over-allotment was gobbled quickly by high-quality investors. About 4 times more demand than supply. And all new investors are high quality buy-and-hold investors (not toxic sharks). This is not an investment advice. Do your own research.

User Image kornlover Posted - 1 month ago

$CGTX https://www.pharmexec.com/view/navigating-the-cbd-research-landscape-unveiling-best-practices-in-the-post-mmcrea-era

User Image Stocksrunner Posted - 1 month ago

Can't Sleep? Neither Can The Market 🔄 Insider Trading Recap 🔄 📈 Recent insider buying: $CROX Director John B. Replogle buys $249K in stock. $CGTX Insider activity suggests positive outlook. 📉 Recent insider selling: $TSLA Ark Invest buys $35M of Tesla stock after selloff. $SNAP Insider sells $307K worth of Watts Water Tech stock. Stay informed for potential market movements!

User Image celebratelife Posted - 1 month ago

$CGTX I like it. The stock has a lot of life in it. Good volume. Two 115k blocks traded today.

User Image NetworkNewsWire Posted - 1 month ago

BioMedNewsBreaks – $CGTX Closes on $11.5M Public Offering https://ibn.fm/EBy4Q

User Image Stock_Titan Posted - 1 month ago

$CGTX Cognition Therapeutics to Report Fourth Quarter and Full Year 2023 Results https://www.stocktitan.net/news/CGTX/cognition-therapeutics-to-report-fourth-quarter-and-full-year-2023-g77z8oykc396.html

User Image CEOBuysDisclosures Posted - 1 month ago

$CGTX CEO purchased 5,700 shares at $1.75 for a total of $9,975. Ricciardi Lisa now owns 291,345 shares. https://ceo-buys.com

Analyst Ratings
B. Riley Securities Buy Mar 28, 24
Oppenheimer Outperform Mar 27, 24
Ladenburg Thalmann Buy Aug 14, 23
Oppenheimer Outperform May 9, 23
Oppenheimer Outperform Mar 24, 23
Cantor Fitzgerald Overweight Sep 29, 22
Ladenburg Thalmann Buy Apr 22, 22
Oppenheimer Outperform Nov 3, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Fletcher Aaron G.L. Director Director Nov 28 Buy 2.65 16,064 42,570 309,748 11/29/22
Kreis Leslie W. Director Director Nov 28 Buy 2.65 16,064 42,570 309,748 11/29/22
Fletcher Aaron G.L. Director Director Nov 16 Buy 1.4 71,000 99,400 307,877 11/17/22
Kreis Leslie W. Director Director Nov 16 Buy 1.4 71,000 99,400 307,877 11/17/22
Fletcher Aaron G.L. Director Director Nov 15 Buy 1.2 1,500,000 1,800,000 299,608 11/16/22
Kreis Leslie W. Director Director Nov 15 Buy 1.2 1,500,000 1,800,000 299,608 11/16/22
BIOS Memory SPV I, LP 10% Owner 10% Owner Oct 13 Buy 12 190,000 2,280,000 899,905 10/15/21
BIOS Memory SPV I, LP 10% Owner 10% Owner Oct 13 Sell 12 90 1,083 385,248 10/15/21
Fletcher Aaron G.L. Director Director Oct 13 Buy 12 190,000 2,280,000 899,905 10/15/21
Fletcher Aaron G.L. Director Director Oct 13 Sell 12 90 1,083 385,248 10/15/21
Golden Seeds Cognition Therape... 10% Owner 10% Owner Oct 13 Sell 12 33 397 2,177,985 10/15/21
Ogden CAP Associates, LLC 10% Owner 10% Owner Oct 13 Sell 12 74 889 2,210,377 10/15/21
Breedlove Mark H. Director Director Oct 13 Sell 12 12 141 404,439 10/15/21